Psychiatr. pro Praxi, 2008; 9(1): 15-18 [Neurol. praxi. 2007;8(5):295-298]
Behavioral disorders in patients with Alzheimer disease
- Psychiatrická klinika 1. LF UK a VFN Praha
One of the three basic involvement in Alzheimer disease and other types of dementia are (besides impairment of cognitive function and activities of daily life) so called behavioral and psychological symptoms of dementia. These disorders include also involvement of emotivity (depression, anxiety, etc.) sleeping disorders and sleeping-vigilance cycle impairment and also behavioral disorders. These disorders are sometimes the most dominant and most disturbing, especially in middle and advanced stages of the disease. They may have different forms. Agitation-persistent and sometimes only slight restlessness is very frequent. Psychotic symptoms sometimes accompany behavioral disorders, e.g. delusions, hallucinations, misinterpretation. Options of agitation treatment are discussed.
Keywords: Alzheimer disease, antipsychotics, dementia, behavioral disorder, agitation
Published: February 1, 2008 Show citation
References
- Bayer A, Reban J (eds.): Alzheimer's disease and related dementias. Medea Press, 2004, 330 s.
- Brodaty H, Ames D, Snowden J et al. A randomized placebo-controlled trial of risperidone for the treatment of agression, agitation, and psychosis of dementia. J Clin Psychiatry, 2003; 64: 134-143.
Go to original source... 
Go to PubMed... - Caltagirone C, Bianchetti A, Di Luca M et al. Guidelines for the treatment of Alzheimer´s disease from the Italian Association of Psychogeriatrics. Drugs & Aging 2005; 22 Suppl. 1: 1-26. Go to original source... Go to PubMed...
- Jirák R, Koukolík F. Demence. Galen, Praha, 2004, 335 s.
- Jirák R, Borzová C, Konrád J, Franková V, Spousta S. Demence. In: Psychiatrie, doporučené postupy psychiatrické péče II, ed. Raboch J, Anders M, Praško J. Hellerová P. Infopharm, Praha, 2006, s. 22-37.
- Katz I, Jeste DV, Mintzer JE et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. J Clin Psychiatry, 1999; 60: 107-115. Go to original source... Go to PubMed...
- Longeran E, Luxenberg J, Colford J. Haloperidol for agitation in dementia. Cochrane Database Syst Rev. 2002; 2: CD002852. Go to original source...
- Meehan KM, Wang H, David SR et al. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a doubleblind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology, 2002; 26: 494-504. Go to original source... Go to PubMed...
- Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J AM Geriatr Soc. 1990; 38: 553-563. Go to original source... Go to PubMed...
- Street JS, Clark WS, Gannon KS et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: A double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry, 2000; 57: 968-976. Go to original source... Go to PubMed...